Thermochemotherapy in patients with extremity high-risk soft tissue sarcomas (HR-STS)

International Journal of Hyperthermia

Volumn 26, Issue 2, 2010, Pages 127-135

  Schlemmer, M ^a   Wendtner, C M ^a   Lindner, L ^a   Abdel Rahman, S ^a   Hiddemann, W ^a   Issels, R D ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Chemotherapy; Extremity sarcoma; Hyperthermia; Multimodality

Indexed keywords

DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE;

ADULT; AGED; ALOPECIA; AMPUTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERTHERMIC THERAPY; INFECTION; LEUKOPENIA; LIMB TUMOR; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; PAIN; PREDICTION; PYREXIA IDIOPATHICA; SOFT TISSUE SARCOMA; SURVIVAL TIME; THERAPY EFFECT; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROSPECTIVE STUDIES; SARCOMA; YOUNG ADULT;

EID: 77149155662     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656730903335995     Document Type: Article

References (28)

1. Scaife CL, Pisters PW. Combined-modality treatment of localized soft tissue sarcomas of the extremities. Surg Oncol Clin N Am 2003;12:355-368
2. McKee MD, Liu DF, Brooks JJ, Gibbs JF, Driscoll DL, Kraybill WG. The prognostic significance of margin width for extremity and trunk sarcoma. J Surg Oncol 2004;85:68-76
3. Sojadinovic A, Leung DH, Hoos A, Jaques DP, Lewis JJ, Brennan MF. Analysis of the prognostic significance of microscopic margins in 2084 localized primary adult soft tissue sarcomas. Ann Surg 2002;235:424-434
4. Bielack SS, Machatschek JN, Flege S, Jurgens H. Delaying surgery with chemotherapy for osteosarcoma of the extremities. Expert Opin Pharmacother 2004;5:1243-1256
5. Noorda EM, Vrouenraets BC, Nieweg OE, van Coevorden F, van Slooten GW, Kroon BB. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities. Cancer. 2003;98:1483-1490
6. Weitz J, Antonescu CR, Brennan MF. Localized extremity soft tissue sarcoma: Improved knowledge with unchanged survival over time. J Clin Oncol 2003;21:2719-2725
7. Falk MH, Issels RD. Hyperthermia in oncology. Int J Hyperthermia 2001;17:1-18
8. Issels RD, Prenninger SW, Nagele A, Boehm E, Sauer H, Jauch KW, Denecke H, Berger H, Peter K, Wilmanns W. Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: A phase II study. J Clin Oncol 1990;8:1818-1829
9. Issels RD, Abdel-Rahman S, Wendtner C, Falk MH, Kurze V, Sauer H, Aydemir U, Hiddemann W. Neoadjuvant chemotherapy combined with regional hyperthermia for locally advanced primary or recurrent high-risk soft tissue sarcomas of adults: Follow-up report of a phase II study. Eur J Cancer 2001;37:1599-1608 (Pubitemid 32778604)
10. Wendtner C-M, Abdel-Rahman S, Baumert J, Falk MH, Krych M, Santl M, Hiddemann W, Issels RD. Treatment of primary, recurrent or inadequately resected high-risk soft tissue sarcomas HR-STS of adults: Results of a phase II pilot study RHT-95 of neoadjuvant chemotherapy combined with regional hyperthermia. Eur J Cancer 2001;37:1609-1616 (Pubitemid 32778605)
11. Wendtner CM, Abdel-Rahman S, Krych M, Baumert J, Lindner LH, Baur A, Hiddemann W, Issels RD. Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas. J Clin Oncol 2002;20:3156-3164
12. Van der Zee J, González González D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumors: A prospective, randomised, multicentre trial - Dutch Deep Hyperthermia Group. Lancet 2000;355:1119-1125
13. Trotti A, Byhardt R, Stetz J, Gwede C, Corn B, Fu K, Gunderson L, McCormick B, Morrisintegral M, Rich T, Shipley W, Curran W. Common toxicity criteria version 2.0: An improved reference for grading the acute effects of cancer treatment - Impact on radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:13-47
14. Mann HB, Whitney DR. On a test of whether one of 2 random variables is stochastically larger than the other. Ann Math Stat 1947;18:50-61
15. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481
16. Greenwood M. The natural duration of cancer: Reports on public health and medical subjects. Vol.33. London: Her Majestys Stationery Office; 1926. pp 1-26
17. Anderson JR, Cain KC, Gelber RD. Analysis of survival by tumor response. J Clin Oncol 1983;1:710-719
18. Lindner NJ, Scarborough MT, Spanier SS, Enneking WF. Local host response in osteosarcoma after chemotherapy referred to radiographs, CT, tumor necrosis and patient survival. J Cancer Res Clin Oncol 1998;124:575-580
19. Picci P, Böhling T, Bacci G, Ferrari S, Sangiorgi L, Mercuri M, Ruggieri P, Manfrini M, Ferraro A, Casadei R, et al. Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J Clin Oncol 1997;15:1553-1559
20. Pisters PW. Chemoradiation treatment strategies for localized sarcoma: Conventional and investigational approaches. Sem Surg Oncol 1999;17:66-71
21. Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996;14:1679-1689
22. Pezzi CM, Pollock RE, Evans HL, Lorigan JG, Pezzi TA, Benjamin RS, Romsdahl MM. Preoperative chemotherapy for soft-tissue sarcomas of the extremeties. Ann Surg 1990;211:476-481
23. Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma specific death. J Clin Oncol 2002;20:791-796
24. Eilber FC, Rosen G, Eckhardt J, Forscher C, Nelson SD, Selch M, Dorey F, Eilber FR. Treatment-induced pathologic necrosis: A predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol 2001;19:3203-3209
25. DeLaney T, Spiro IJ, Suit HD, Gebhardt MC, Hornicek FJ, Mankin HJ, Rosenberg AL, Rosenthal DI, Miryousefi F, Ancukiewicz M, et al. Neoadjuvant chemotherapy and radiotherapy for large extremity soft tissue sarcomas. Int J Rad Oncol Biol Phys 2003;56:1117-1127
26. Lewis J, Leung D, Casper E, Woodruff J, Hajdu SI, Brennan MF. Multifactorial analysis of long term follow-up more than 5 years of primary extremity sarcoma. Arch Surg 1999;134:190-194
27. Frustaci S, Gherlinzoni F, DePaoli A, Bonetti M, Azzarelli A, Comandone A, Olmi P, Buonadonna A, Pignatti G, Barbieri E, et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: Results of the Italian Cooperative trial. J Clin Oncol 2001;19:1238-1247
28. Woll PJ, van Glabbeke M, Hohenberger H, Le Cesne A, Gronchi A, Hoekstra HJ, Radford JA, van Coevorden F, Blay J. Adjuvant chemotherapy with doxorubicin and ifosfamide in resected soft tissue sarcoma: Interim analysis of a randomised phase III trial. ASCO Annual Proceedings 2007;25:10008